On Sept. 24, 2026, Eli Lilly and Company announced the U.S. Food and Drug Administration (FDA) approval of Onswik™ (insulin…
On Sept. 24, 2026, a new study from Washington University School of Medicine in St. Louis of nearly…
On Sept. 23, 2026, SystImmune announces the U.S. Food and Drug Administration (FDA) has cleared its Investigational New…
On Sept. 23, 2026, Nike co-founder Phil Knight and his wife, Penny Knight, announced they have committed $1…
On Sept. 23, 2026, research led by Mount Sinai scientists within the PsychAD Consortium, a large-scale, multidisciplinary initiative…
On Sept. 22, 2026, three current and former Harvard researchers announced they are heading north to Canadian universities…
On Sept. 21, 2026, the U.S. Department of Health and Human Services (HHS) announced a new wave of…
On Sept. 20, 2026, Telix announces it has signed a strategic agreement to lead a merger with ITM…
On Sept. 18, 2026, a study led by Stanford Medicine found the brain is two separate organs adjacent…
On Sept. 18, 2026, Eli Lilly and Company announced that the U.S. Food and Drug Administration(FDA) has granted…
On Sept. 17, 2026, Ultragenyx Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) granted standard full…
On Sept. 17, 2026, investigators at Dana-Farber Cancer Institute and 23andMe Research Institute report that a rare inherited…
On Sept. 17, 2026, Bayer announced that the U.S. Food and Drug Administration (FDA) approved KERENDIA® (finerenone) to…
On Sept. 16, 2026, an analysis of more than 60,000 respiratory syncytial virus (RSV) sequences from around the…
On Sept. 16, 2026, a new discovery by neuroscientists at Brown University’s Carney Institute for Brain Science challenges…
On Sept. 16, 2026, The Lost Funds Project, a comprehensive resource tracking federal funding disruptions and their impacts…
On Sept. 16, 2026, researchers at Maynooth University (MU) have developed a first-of-its-kind DNA computer, described as one…
On Sept. 15, 2026, Oregon billionaires Phil and Penny Knight committed $1.1 billion to the Providence St. Vincent…
On Sept. 15, 2026, the Pennsylvania Department of Health (DOH) confirmed two additional measles-associated deaths in Pennsylvania. Both…
On Sept. 15, 2026, the New York State Department of Health announces the launch of its new Measles…
On Sept. 15, 2026, the U.S. Food and Drug Administration announced the final design of the Expedited Investigational…
On Sept. 14, 2026, bacteria that cause potentially fatal Legionnaires’ disease were found in a Yankee Stadium cooling…
On Sept. 14, 2026, Paradromics, a neurotechnology company developing a high-data-rate brain-computer interface (BCI) platform designed to restore…
On Sept. 14, 2026, Telix today announces that the U.S. Food and Drug Administration (FDA) has approved its…
On Sept. 11, 2026, the Pennsylvania Department of Health (DOH) announced that 676 measles cases have been confirmed…
On Sept. 10, 2026, Lasker~Bloomberg Public Service Award honors Michael J. Fox (Michael J. Fox Foundation for Parkinson’s…
On Sept. 10, 2026, philanthropist and entrepreneur Tom Golisano announced a $225 million investment in six children’s hospitals,…
On Sept. 10, 2026, Lonza, the world’s leading contract development and manufacturing organization (CDMO), announced plans to further…
On Sept. 9, 2026, the Albert Lasker~DeBakey Clinical Medical Research Award honored three scientists for inventing a bispecific…
On Sept. 9, 2026, the World Health Organization (WHO) announced it has prequalified the multi-dose vial presentation of…